|Year : 2022 | Volume
| Issue : 1 | Page : 18
Use of amniotic membrane ameliorating postoperative discomfort in pterygium surgery
Luis F Mejia, Juan C Gil
Department of Ophthalmology, CES University, Medellín, Colombia
|Date of Submission||24-Jan-2022|
|Date of Acceptance||01-Feb-2022|
|Date of Web Publication||20-Apr-2022|
Dr. Luis F Mejia
Cra 25A #1-31, Ofic 914, Medellin
Source of Support: None, Conflict of Interest: None
Purpose: To report the results of using human amniotic membrane (AM) as a bandage at the end of pterygium surgery to diminish its uncomfortable postoperative symptoms.
Materials and Methods: Observational, descriptive retrospective study in which patients with bilateral primary nasal pterygia were operated on with a conjunctival-limbal autograft with conventional suturing, one eye receiving an AM bandage at the end of surgery and the other not.
Results: There were 20 eyes of 10 patients, five men, and five women, with a mean age of 28.7 ± 6.4 years; general postoperative symptoms (pain, burning sensation, and tearing) and foreign body sensation were statistically lower in the AM group at the 4th, 8th, and 12th postoperative day (P < 0.05).
Conclusions: AM as a bandage at the end of pterygium surgery reduces the uncomfortable postoperative symptoms typical of such surgery.
Keywords: Amniotic membrane, pain, pterygium
|How to cite this article:|
Mejia LF, Gil JC. Use of amniotic membrane ameliorating postoperative discomfort in pterygium surgery. Pan Am J Ophthalmol 2022;4:18
|How to cite this URL:|
Mejia LF, Gil JC. Use of amniotic membrane ameliorating postoperative discomfort in pterygium surgery. Pan Am J Ophthalmol [serial online] 2022 [cited 2023 Feb 6];4:18. Available from: https://www.thepajo.org/text.asp?2022/4/1/18/343601
| Introduction|| |
Pterygium surgery has advanced enormously during the last decades, evolving from simple resections - the bare sclera - with recurrence rates >60% to conjunctival-limbal autografts (CLAG) with lower recurrence rates, even lower than 2%.,,, Initially reports were centered on reducing the recurrence rate, moving on from bare sclera to sliding conjunctival grafts; then free conjunctival autografts and finally to free CLAG.,,,
During this time, several adjuvant techniques have been proposed such Beta-Radiation,, topical mitomycin C (MMC),,, and 5-Fluorouracil (5-FU),, among others, with variable results, finally proving the free CLAG as the best technique, providing an adequate anatomic and functional reconstruction of the ocular surface, reported by different groups worldwide.,,,,
During the last decade, focus has centered on ameliorating the noisome postoperative symptoms during the early postoperative period of this surgery. Such symptoms have several causes: Tissue cut and resection, corneal-limbal smoothing, hemostasis, and sutures.
In this regard, several techniques have been tried, such as graft fixation with tissue adhesive,, or cautery, different suturing materials,,, therapeutic contact lenses,,, peribulbar morphine, autologous serum, lidocaine gel, and peribulbar Bupivacaine among others, with variable results, that in the best of cases variably diminish these symptoms mainly during the first 24 postoperative hours.
Nowadays, some groups consider fibrin glue and CLAG as a gold standard in pterygium surgery, being faster and with lesser immediate postoperative pain, not only because of the absence of sutures but also because the glue itself serves as a temporary bandage over the surgical wound. However, regarding recurrences, it has not shown better results than conventional suturing techniques, and in many third-world countries, the cost of tissue adhesive makes it harder to be used.
In our institution, the CLAG is used as the standard technique for pterygium surgery, finding the noisome postoperative discomfort mentioned above; we have tried several techniques to diminish such symptoms, such as commercial and autologous adhesive, fixation by cautery, and postoperative soft contact lens placement. Even though symptoms are more or less ameliorated, this surgery is still very uncomfortable for patients.
The use of amniotic membrane (AM) as a postoperative symptom and pain reliever has not been considered in the literature. The purpose of this study is to present our results regarding the striking decrease in unpleasant postoperative symptoms in pterygium surgery with the sutured conventional CLAG technique and a novel usage for AM by temporarily covering the surgical area at the end of surgery with glycerin-preserved human AM using it as both: A mechanical and chemical bandage.
| Materials and Methods|| |
A retrospective descriptive study with data from operated patients with the technique mentioned above.
We included ten patients with bilateral primary nasal pterygium to whom the experimental nature of the procedure was explained and who understood and accepted it.
This study was accepted by the ethics committee of Universidad CES and adhered to the Helsinki protocol principles.
Each patient's eyes were operated upon: One with AM and the other not, with a 2 weeks' interval, so that each patient served as his control. All patients were operated by one surgeon (LFM) using the same surgical technique consisting of complete removal of the anomalous tissue with a 15° disposable knife and Wescott scissors, corneal-limbal smoothening with a high-speed diamond drill, and a CLAG sutured with 7 10-0 Nylon sutures, finalizing by closure of the graft donor site with 2 10-0 Nylon sutures. Upon finishing surgery, the surgical area was covered with glycerin preserved human AM, epithelial side up, secured with 4 10-0 nylon amniotic-conjunctival sutures on its corners (GROUP A); this membrane covered the corneal de-epithelized area, and the CLAG with its seven anchoring sutures [Video 1].
Upon finishing surgery, the contralateral eye's surgical area was not covered with an AM (Group B).
Eyes were left patched for 24 h, after which they were uncovered, and started using fluorometholone drops 5 times per day, preservative-free artificial tears five times per day and dexamethasone + moxifloxacin ointment every night, for 2 weeks; after this, the liberal use of preservative-free artificial tears was left to the patient's choice.
The AM (Group A) was removed on the fourth postoperative day at the slit lamp, and all the CLAG sutures were removed at the 12th postoperative day (Group A and B).
The diagnosis of pterygium was confirmed by pathology in all cases.
Postoperative discomfort was evaluated using an analogous score and was divided into two categories: Pain, burning sensation, and tearing, classified as general symptoms, and foreign body sensation, produced mainly by the suturing material.
Patients were given a form with a graphic pain score graded 0–5 to evaluate separately the magnitude of the general symptoms and foreign body sensation, were 0 is no uncomfortable symptoms or foreign body sensation at all, and five is incapacitating symptoms or foreign body sensation. This form was filled on the 4th, 8th, and 12th postoperative days. This form is used in every pterygium surgery at our institution. Thereby information and data bias were controlled.
Data collection and statistical analysis
Due to the descriptive nature of this study, an analysis of every patient's medical record was made, recording the required variables as the dependent variable was considered the presence or not of AM. Nondependent variables were general symptoms and foreign body sensation at the 4th, 8th, and 12th postoperative days.
Categorical variables are presented both in percentage and absolute value, and numerical variables are presented in media and standard deviation, based on the normal distribution according to the Shapiro–Wilk Test.
Furthermore, a bivariate analysis was performed with the U-Test of Mann–Whitney for independent samples and the Chi-square Test looking for probable associations.
We considered acceptable values an alpha of 0.05, a potency of 80%, and a confidence of 95%.
Data were tabulated on Microsoft Excel v 16.37 and analysis was performed using IBM. Chicago, Illinois, USA. v 21.00 for IOS.
| Results|| |
We operated on 20 eyes of 10 patients, five men and five women, with a mean age of 28.7 ± 6.4 years In 50% of cases, AM was placed on the first operated eye, and in the other 50% in the secondly operated eye.
The diagnosis of pterygium was confirmed by pathology in all cases.
Results of general symptoms and foreign body sensation gradation are shown in [Table 1].
Postoperative general symptoms (pain, burning sensation, and tearing) were statistically lower in Group A, compared to Group B, in all measurements, even up to the 12th postoperative day control (P < 0.05).
Postoperative foreign body sensation, mainly caused by sutures, was also statistically lower in Group A, compared to Group B, at all times, up to the 12th postoperative day (P < 0.05).
Overall, patients in GROUP A had quieter eyes, with less hyperemia, and less CLAG and palpebral edema [Figure 1], compared to eyes in GROUP B [Figure 2].
|Figure 1: (a) Typical 4th day postop aspect of a Group A eye. (b) Typical 8th day postop aspect of a Group A eye|
Click here to view
|Figure 2: (a) Typical 4th day postop aspect of a Group B eye. (b) Typical 8th day postop aspect of a Group B eye|
Click here to view
| Discussion|| |
Pterygium surgery is performed worldwide. Cameron described what is known as the “pterygium belt” limited at ± 35° North and South of the Equatorial line as a zone of greater incidence due to environmental factors.
This surgery has been performed for centuries. The initial challenge was to achieve a good anatomical and functional reconstruction with low recurrences.
Recurrence rate improved with new techniques, as follows: Bare sclera >60%, sliding conjunctival graft 4% to 16.6%, free conjunctival autograft 8%-10%, and finally, CLAG first described by Jose Barraquer MD and nowadays deemed the procedure of choice with results confirmed worldwide of recurrence rates as low as 1.8%.,,,,, During these years several additional techniques have been proposed to lower the recurrence rate but not reaching consistently similar results to the CLAG, such as AM graft, or even with deleterious effects such as Beta radiation therapy,, or intra or postoperative MMC application.,,
However, a problem that has persisted thru all these years is the severe postoperative pain and discomfort in these patients.
In this regard, several adjuvant therapies have been proposed, such as:
- Peribulbar Morphine decreased postoperative pain in the first 24 h only, and secondary effects such as nausea
- Subtenon's Bupivacaine, decreased postoperative pain in the first 36 h
- Therapeutic soft contact lens, resulting in variable improvement in the postoperative pain in the first 48 h in some reports, but not in others
- Commercial or autologous tissue adhesive;,,,,,,, most reports a decrease in pain and discomfort scores, but still with some symptoms during the early postoperative days; adhesive cost is high and has some risk of graft dislocation and rarely a graft loss
- Autologous serum; reporting low uncomfortable claims during the early postoperative period compared to sutures, but with dislodgement and graft loss incidence of up to 10%
- Electrocautery graft fixation; lesser symptoms than sutures or tissue adhesive,, but considerable discomfort during the early postoperative period
- Different eye drops during the postop such as cyclopentolate, Nepafenac or autologous serum with improvement in postoperative symptoms during the first 2–3 days, but with inherent disadvantages such as the nuisance of prolonged cycloplegia, or the risk of corneal melting using nepafenac in a de-epithelialized cornea
- Compared to conventional nylon sutures, different suturing materials such as polyglactin, have no symptoms of improvement.,
The common denominator to all these measures has been a slight amelioration of early postoperative symptoms, never lasting longer than 3 days.
In our group, we have worked for years to ameliorate the bothersome postoperative symptoms of our pterygium surgery patients and, even though we have seen some early (up to 3 days) postoperative symptoms amelioration. However, this relief does not extend beyond 3 days, and our patients regularly complain of pain, foreign body sensation, epiphora and lid edema with the different therapies tried.
AM is avascular, antiangiogenic, does not express histocompatibility antigens, has antibacterial properties, and is a known source of Interleukins1 and 10 (IL-1, IL-10) and metalloproteinase Tissue Inhibitor 1, 2, and 4 among other factors, which makes it not only a mechanical but also a biochemical bandage.,,,,
Keeping all that in mind, we decided to place the AM as a bandage over the surgical area, covering the corneal de-epithelialized area and the CLAG and its sutures. Looking forward to ameliorating their postoperative symptoms in two ways: Mechanically by avoiding the eyelid friction over the surgical area, and biochemically by taking advantage of the biochemical properties of the AM to have a quieter and less inflamed ocular surface overall; suturing the AM in place did not take more than a few minutes of extra surgical time.
We opted to leave it on for only 4 days because those are the most uncomfortable days, because its aspect is cosmetically unpleasant and because we wanted to remove it before it began to disintegrate. Leaving it on for 4 days proved to be very effective, providing almost complete relief of the described general symptoms and foreign body sensation never seen before in our hands with all the other techniques tried, clearly reaching a statistically significant relevance between groups in the questionnaires filled at not only 4 days but also 8 and 12 postoperative days [Table 1].
Despite being removed on the fourth postoperative day, Group A eyes were quieter, and CLAG's with less edema than Group B patients, a difference that persisted until the 12th postoperative day when graft sutures were removed in both groups.
AM effects persisted after its removal as if the lesser inflammation obtained during the first 4 days helped to have a remaining postoperative period more accessible for these eyes.
Glycerin preserved AM is cheap and widely available in our country, its cost is considerably lower than the tissue adhesive, which is considerably expensive for the general public in our country; furthermore, the AM is provided by the public health system, while the tissue adhesive is not, so patients must pay for it. Moreover, in Colombia, we do not have access to AM in contact lens nor cryopreserved as other countries do, so we cannot comment on these variations.
We did not have any immediate complications regarding CLAG displacement or retraction under the AM or even the AM itself being dislodged, although the latter could certainly happen if one of its suture knots is broken; we do not expect this technique to modify our recurrence rate, but only time will tell.
A limitation of this study is that this technique was not directly compared to other discomfort amelioration methods, but our past published experience has shown some different pain scores using the same visual pain grading system.
In our hands, AM was an effective coadjutant for ameliorating uncomfortable symptoms and foreign body sensation after pterygium surgery. We were pleasantly surprised by the overall well-being of these patients, independent of their personality, as each patient served as its own control, and we contemplate that AM may be considered as a routine adjuvant for pterygium surgery.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Sánchez-Thorin JC, Rocha G, Yelin JB. Meta-analysis on the recurrence rates after bare sclera resection with and without mitomycin C use and conjunctival autograft placement in surgery for primary pterygium. Br J Ophthalmol 1998;82:661-5.
Mejía LF, Sánchez JG, Escobar H. Management of primary pterygia using free conjunctival and limbal-conjunctival autografts without antimetabolites. Cornea 2005;24:972-5.
Ti SE, Chee SP, Dear KB, Tan DT. Analysis of variation in success rates in conjunctival autografting for primary and recurrent pterygium. Br J Ophthalmol 2000;84:385-9.
Alsarhani W, Alshahrani S, Showail M, Alhabdan N, Alsumari O, Almalki A, et al.
Characteristics and recurrence of pterygium in Saudi Arabia: A single center study with a long follow-up. BMC Ophthalmol 2021;21:207.
Huerva V, March A, Martinez-Alonso M, Muniesa MJ, Sanchez C. Pterygium surgery by means of conjunctival autograft: Long term follow-up. Arq Bras Oftalmol 2012;75:251-5.
Sune MP, Sune PG. Conjunctival rotation autograft for pterygium: An alternative to conventional conjunctival autografting. Asia Pac J Ophthalmol (Phila) 2013;2:227-31.
Serrano F. Plastia conjuntival libre en la cirugía del pterigion. Arch Soc Am Oftal Optom 1977;12:97-102.
Barraquer JI. The corneo-conjuctival limbus reconstruction before corneal grafting. In: Cornea World Congress. Washington, Butterworths: King JH McTigue; 1965. p. 351-4.
Zheng K, Cai J, Jhanji V, Chen H. Comparison of pterygium recurrence rates after limbal conjunctival autograft transplantation and other techniques: Meta-analysis. Cornea 2012;31:1422-7.
Masters JS, Harris DJ Jr. Low recurrence rate of pterygium after excision with conjunctival limbal autograft: A retrospective study with long-term follow-up. Cornea 2015;34:1569-72.
Clearfield E, Muthappan V, Wang X, Kuo IC. Conjunctival autograft for pterygium. Cochrane Database Syst Rev 2016;2:CD011349.
Zeng W, Liu Z, Dai H, Yan M, Luo H, Ke M, et al.
Anti-fibrotic, anti-VEGF or radiotherapy treatments as adjuvants for pterygium excision: A systematic review and network meta-analysis. BMC Ophthalmol 2017;17:211.
Viani GA, Fonseca EC, De Fendi LI, Rocha EM. Conjunctival autograft alone or combined with adjuvant beta-radiation? A randomized clinical trial. Int J Radiat Oncol Biol Phys 2012;82:e507-11.
Kheirkhah A, Izadi A, Kiarudi MY, Nazari R, Hashemian H, Behrouz MJ. Effects of mitomycin C on corneal endothelial cell counts in pterygium surgery: Role of application location. Am J Ophthalmol 2011;151:488-93.
Bahar I, Kaiserman I, Lange AP, Slomovic A, Levinger E, Sansanayudh W, et al.
The effect of mitomycin C on corneal endothelium in pterygium surgery. Am J Ophthalmol 2009;147:447-52.e1.
Wan Norliza WM, Raihan IS, Azwa JA, Ibrahim M. Scleral melting 16 years after pterygium excision with topical Mitomycin C adjuvant therapy. Cont Lens Anterior Eye 2006;29:165-7.
Bekibele CO, Baiyeroju AM, Olusanya BA, Ashaye AO, Oluleye TS. Pterygium treatment using 5-FU as adjuvant treatment compared to conjunctiva autograft. Eye (Lond) 2008;22:31-4.
Lewallen S. A randomized trial of conjunctival autografting for pterygium in the tropics. Ophthalmology 1989;96:1612-4.
Gris O, Güell JL, del Campo Z. Limbal-conjunctival autograft transplantation for the treatment of recurrent pterygium. Ophthalmology 2000;107:270-3.
Güler M, Sobaci G, Ilker S, Oztürk F, Mutlu FM, Yildirim E. Limbal-conjunctival autograft transplantation in cases with recurrent pterygium. Acta Ophthalmol (Copenh) 1994;72:721-6.
Ozdamar Y, Mutevelli S, Han U, Ileri D, Onal B, Ilhan O, et al.
A comparative study of tissue glue and vicryl suture for closing limbal-conjunctival autografts and histologic evaluation after pterygium excision. Cornea 2008;27:552-8.
Reinoso S. Cirugía del pterigion mediante Aerorotor. Arch Soc Am Oftal Optom 1977;12:109-30.
Por YM, Tan DT. Assessment of fibrin glue in pterygium surgery. Cornea 2010;29:1-4.
Xu F, Li M, Yan Y, Lu K, Cui L, Chen Q. A novel technique of sutureless and glueless conjunctival autografting in pterygium surgery by electrocautery pen. Cornea 2013;32:290-5.
Rubin MR, Dantas PE, Nishiwaki-Dantas MC, Felberg S. Efficacy of fibrin tissue adhesive in the attachment of autogenous conjuntival graft on primary pterygium surgery. Arq Bras Oftalmol 2011;74:123-6.
Lešin M, Paradžik M, Marin Lovrić J, Olujić I, Ljubić Ž, Vučinović A, et al.
Cauterisation versus fibrin glue for conjunctival autografting in primary pterygium surgery (CAGE CUP): Study protocol of a randomised controlled trial. BMJ Open 2018;8:e020714.
Miranda-Rollón MD, Pérez-González LE, Sentieri-Omarrementería A, Martínez-Rodríguez R, Parente-Hernández B, Junceda-Moreno J. Pterygium surgery: Comparative study of conjunctival autograft with suture versus fibrin adhesive. Arch Soc Esp Oftalmol 2009;84:179-84.
Huang X, Zhu B, Lin L, Jin X. Clinical results for combination of fibrin glue and nasal margin suture fixation for attaching conjunctival autografts after pterygium excision in Chinese pterygium patients. Medicine (Baltimore) 2018;97:e13050.
Yüksel B, Unsal SK, Onat S. Comparison of fibrin glue and suture technique in pterygium surgery performed with limbal autograft. Int J Ophthalmol 2010;3:316-20.
Arenas E, Garcia S. A scleral soft contact lens designed for the postoperative management of pterygium surgery. Eye Contact Lens 2007;33:9-12.
Yeung SN, Lichtinger A, Kim P, Elbaz U, Ku JY, Teichman JC, et al.
Efficacy and safety of patching vs. bandage lens on postoperative pain following pterygium surgery. Eye (Lond) 2015;29:295-6.
Daglioglu MC, Coskun M, Ilhan N, Tuzcu EA, Ilhan O, Keskin U, et al.
The effects of soft contact lens use on cornea and patient's recovery after autograft pterygium surgery. Cont Lens Anterior Eye 2014;37:175-7.
Wishaw K, Billington D, O'Brien D, Davies P. The use of orbital morphine for postoperative analgesia in pterygium surgery. Anaesth Intensive Care 2000;28:43-5.
Sul S, Korkmaz S, Alacamli G, Ozyol P, Ozyol E. Application of autologous serum eye drops after pterygium surgery: A prospective study. Graefes Arch Clin Exp Ophthalmol 2018;256:1939-43.
Pereira F, Shiroma HF, Urias MG, Yamada VH, Lima AA, Hofling-Lima AL, et al.
Pilot study comparing topical anesthetic agents in pterygium surgery: Subconjunctival injection versus 2% lidocaine gel versus 5% lidocaine gel. Cornea 2018;37:194-8.
Bhikoo R, Hughes K, Vather R, Murphy C. Subtenon bupivacaine for postoperative pain in patients undergoing pterygium excision: A double-blinded randomized control trial. Cornea 2019;38:959-63.
Mejía LF, Santamaría JP, Cuevas M, Córdoba A, Carvajal SA. Comparison of 4 techniques for limbal-conjunctival autograft fixation in primary pterygium surgery. Eur J Ophthalmol 2017;27:466-9.
Aidenloo NS, Motarjemizadeh Q, Heidarpanah M. Risk factors for pterygium recurrence after limbal-conjunctival autografting: A retrospective, single-centre investigation. Jpn J Ophthalmol 2018;62:349-56.
Mery G, Maalouf T, George JL, Angioi K. Limbal-conjunctival autograft in pterygium surgery. J Fr Ophtalmol 2010;33:92-8.
Jha KN. Conjunctival-limbal autograft for primary and recurrent pterygium. Med J Armed Forces India 2008;64:337-9.
Röck T, Bramkamp M, Bartz-Schmidt KU, Röck D. A retrospective study to compare the recurrence rate after treatment of pterygium by conjunctival autograft, primary closure, and amniotic membrane transplantation. Med Sci Monit 2019;25:7976-81.
Prat D, Zloto O, Ben Artsi E, Ben Simon GJ. Therapeutic contact lenses vs. tight bandage patching and pain following pterygium excision: A prospective randomized controlled study. Graefes Arch Clin Exp Ophthalmol 2018;256:2143-8.
Uy HS, Reyes JM, Flores JD, Lim-Bon-Siong R. Comparison of fibrin glue and sutures for attaching conjunctival autografts after pterygium excision. Ophthalmology 2005;112:667-71.
Wang X, Zhang Y, Zhou L, Wei R, Dong L. Comparison of fibrin glue and Vicryl sutures in conjunctival autografting for pterygium surgery. Mol Vis 2017;23:275-85.
Pan HW, Zhong JX, Jing CX. Comparison of fibrin glue versus suture for conjunctival autografting in pterygium surgery: A meta-analysis. Ophthalmology 2011;118:1049-54.
Donepudi GD, Ramesh S, Govindarajulu M, Dhanasekaran M, Moore T, Ganekal S, et al.
Early postoperative outcomes of pterygium surgery: Sutures versus autogenous serum in-situ fixation of limbal conjunctival autograft. Life Sci 2019;221:93-8.
Bahar I, Weinberger D, Dan G, Avisar R. Pterygium surgery: Fibrin glue versus Vicryl sutures for conjunctival closure. Cornea 2006;25:1168-72.
Ratnalingam V, Eu AL, Ng GL, Taharin R, John E. Fibrin adhesive is better than sutures in pterygium surgery. Cornea 2010;29:485-9.
Mejía LF, Santamaría JP, García RA, et al
. Efectividad y seguridad de la utilización de adhesivo de fibrina en cirugía de pterigion. Rev Soc ColombIana Oftalmol 2004;37:149-59.
Zloto O, Greenbaum E, Fabian ID, Ben Simon GJ. Evicel versus tisseel versus sutures for attaching conjunctival autograft in pterygium surgery: A prospective comparative clinical study. Ophthalmology 2017;124:61-5.
Yan B, Peng L, Peng H, Zhou S, Chen B. Modified sutureless and glue-free method versus conventional sutures for conjunctival autograft fixation in primary pterygium surgery: A randomized controlled trial. Cornea 2019;38:1351-7.
Goktas S, Sakarya Y, Ozcimen M, Sakarya R, Alpfidan I, Ivacık IS, et al.
Effect of topical cyclopentolate on post-operative pain after pterygium surgery. Clin Exp Optom 2017;100:595-7.
Ozcimen M, Sakarya Y, Goktas S, Sakarya R, Yener HI, Bukus A, et al.
Effect of nepafenac eye drops on pain associated with pterygium surgery. Eye Contact Lens 2015;41:187-9.
Oguz H. Polyglactin sutures versus nylon sutures for suturing of conjunctival autograft in pterygium surgery. Acta Ophthalmol 2008;86:345.
Russo R G, Thorgeirsson U, Liotta LA. In Vitro
Quantitative Assay of Invasion Using Human Amnion. Liotta L.A: Hart I.R; 1982. p. 173-87 (Developments in Oncology). Available from: https://doi.org/10.1007/978-94-009-7511-8_11
. December 28, 2021.
Akle CA, Adinolfi M, Welsh KI, Leibowitz S, McColl I. Immunogenicity of human amniotic epithelial cells after transplantation into volunteers. Lancet 1981;2:1003-5.
Talmi YP, Sigler L, Inge E, Finkelstein Y, Zohar Y. Antibacterial properties of human amniotic membranes. Placenta 1991;12:285-8.
Tseng SC, Li DQ, Ma X. Suppression of transforming growth factor-beta isoforms, TGF-beta receptor type II, and myofibroblast differentiation in cultured human corneal and limbal fibroblasts by amniotic membrane matrix. J Cell Physiol 1999;179:325-35.
Hao Y, Ma DH, Hwang DG, Kim WS, Zhang F. Identification of antiangiogenic and antiinflammatory proteins in human amniotic membrane. Cornea 2000;19:348-52.
[Figure 1], [Figure 2]